Lv31
214 积分 2021-04-20 加入
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
2小时前
已完结
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials
1个月前
已完结
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial
2个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer
2个月前
已完结
Personalized N-of-1 Combination Therapies for Advanced Gastrointestinal Stromal Tumors
3个月前
已关闭
Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design
3个月前
已完结
An agentic system for rare disease diagnosis with traceable reasoning
5个月前
已完结
Deep-learning-based HER2 status assessment from multimodal breast cancer data predicts neoadjuvant therapy response
7个月前
已完结
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab
8个月前
已完结
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab
8个月前
已完结
皖公网安备34019202002308
